Status
Conditions
Treatments
About
Uncontrolled, multi-centre, non-interventional study with a prospective and a retrospective cohort, to evaluate the efficacy of Wilate or Nuwiq in achieving complete or partial immune tolerance induction (ITI) success in severe and moderate haemophilia A patients with inhibitors
Enrollment
Sex
Volunteers
Inclusion criteria
For patients in the prospective cohort:
For patients in the retrospective cohort:
Exclusion criteria
Patients who meet any of the following criteria are not eligible for the study:
14 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal